Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-09 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-07 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |